MeiraGTx Holdings plc has grown revenue 72% a year over three years and 85% a year over five. Revenue growth, 3-year annual rate: +72% (Biotechnology median +17%). Revenue growth, 5-year rate: +85%, growth has slowed since the five-year average. Years of annual history on file: 9, FY2017 to FY2025, as filed.

MGTXMeiraGTx Holdings plc

Healthcare

$10.69+41% 1Y

$10.69

$6.9952 weeks$14.96

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +948% year on year, but earnings down −135% year on year and operating margin narrowing (−5291.0 points).

1 good, 2 to watch

Revenue trend+948% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +85% a year.

Earnings trend−135% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−5291.0 points operating

Trailing-twelve-month operating margin, -6262.9% now against -971.9% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is MGTX growing?

MeiraGTx Holdings plc has grown revenue 72% a year over three years and 85% a year over five.

+72%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +85%
Revenue growth, 5-year rate · +72% over three · growth has slowed since the five-year average
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›